Do gene mutations impact clinical outcome in elderly acute myeloid leukemia (AML) patients?
BH3 mimetics as potential treatment for AML
Highly targeted medication for AML
Interim results of pegylated interferon alpha-2a for polycythemia vera and essential thrombocythemia
Amyloidosis: patient fitness determines therapeutic strategies